- Home
- VNRX vs CMBM Comparison
VNRX vs CMBM Comparison
Compare VNRX & CMBM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VNRX | CMBM |
|---|---|---|
| Founded | N/A | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Radio And Television Broadcasting And Communications Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 31.9M | 33.6M |
| IPO Year | 2012 | 2019 |
Fundamental Metrics
Financial Performance| Metric | VNRX | CMBM |
|---|---|---|
| Price | $0.20 | $1.25 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $2.50 | N/A |
| AVG Volume (30 Days) | ★ 1.9M | 148.9K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 38.00 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $1,233,511.00 | ★ $220,195,000.00 |
| Revenue This Year | $60.84 | N/A |
| Revenue Next Year | $404.89 | $18.01 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 59.10 | N/A |
| 52 Week Low | $0.17 | $0.23 |
| 52 Week High | $0.94 | $6.80 |
Technical Indicators
Market Signals| Indicator | VNRX | CMBM |
|---|---|---|
| Relative Strength Index (RSI) | 38.77 | 45.90 |
| Support Level | N/A | $1.25 |
| Resistance Level | $0.33 | $1.81 |
| Average True Range (ATR) | 0.03 | 0.09 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 28.48 | 50.91 |
Price Performance
Historical ComparisonAbout VNRX VolitionRX Limited
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.
About CMBM Cambium Networks Corporation
Cambium Networks Corp provides wireless broadband networking infrastructure solutions for network operators, including medium-sized wireless Internet service providers, enterprises, and government agencies. The company geographically operates in North America; Europe, Middle East and Africa; Caribbean and Latin America; and Asia Pacific. It derives maximum revenue from North America.